Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ascendia Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Ascendia Pharmaceuticals

Ascendia Pharmaceuticals

Seed

Ascendia Pharmaceuticals: A nanotech provider enhancing drug solubility and bioavailability for various administrations.

HQ
North Brunswick, NJ, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to enhance drug solubility and bioavailability, Ascendia Pharmaceuticals specializes in nanotechnology-based solutions for preclinical and clinical-stage drug candidates. The company offers a comprehensive suite of pre-formulation services for injectable, oral, and topical drug administration. Its core technology platforms include EmulSol for nano-emulsions, AmorSol for amorphous solid dispersions, and NanoSol for other nano-formulations. Ascendia focuses on addressing the challenges of poorly water-soluble drugs, aiming to improve therapeutic efficacy and patient outcomes.

Ascendia Pharmaceuticals has garnered attention for its innovative approach to drug formulation, attracting notable investors and industry experts. The company has achieved significant milestones in developing formulations that enable rapid progression through early clinical phases. Its impact is evident in the successful enhancement of drug candidates' solubility and bioavailability, contributing to more effective treatments. Ascendia continues to influence the pharmaceutical landscape by providing cutting-edge solutions that address critical formulation challenges.

Ascendia Pharmaceuticals - Similar Companies

Nano PharmaSolutions logo

Nano PharmaSolutions

Nanomedex Pharmaceuticals logo

Nanomedex Pharmaceuticals

Concours Pharmaceuticals logo

Concours Pharmaceuticals

NanoPharmaceuticals logo

NanoPharmaceuticals

Nanocopoeia logo

Nanocopoeia

nanocopoeia.com

PDX Pharmaceuticals logo

PDX Pharmaceuticals

pdxpharm.com

Lypro Biosciences logo

Lypro Biosciences

lyprobio.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Advanced NanoTherapies logo

Advanced NanoTherapies

Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

amphastar.com

Diant Pharma logo

Diant Pharma

diantpharma.com

NMB Therapeutics logo

NMB Therapeutics

Ascent Therapeutics logo

Ascent Therapeutics

Plumb Pharmaceuticals logo

Plumb Pharmaceuticals

plumbpharma.com

Ascenta Therapeutics logo

Ascenta Therapeutics

Ascendia Pharmaceuticals - Quick Facts

Who are Ascendia Pharmaceuticals' competitors?

Companies similar to Ascendia Pharmaceuticals include Nano PharmaSolutions, Nanomedex Pharmaceuticals, Concours Pharmaceuticals and NanoPharmaceuticals.

When was Ascendia Pharmaceuticals founded?

Ascendia Pharmaceuticals was founded in 2012.

Where is Ascendia Pharmaceuticals' headquarters located?

Ascendia Pharmaceuticals' headquarters is located in North Brunswick, NJ, US.

When was Ascendia Pharmaceuticals' last funding round?

Ascendia Pharmaceuticals' most recent funding round was for $2.5M (USD) in July 2022.

How much has Ascendia Pharmaceuticals raised to-date?

As of Jul 13, 2022, Ascendia Pharmaceuticals has raised a total of $2.5M (USD).

How many employees does Ascendia Pharmaceuticals have?

Ascendia Pharmaceuticals has 49 employees as of Feb 5, 2024.

Ascendia Pharmaceuticals - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Nanotechnology
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Drug Formulation
Tags
  • Biotech
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified